Below are the most recent publications written about "Myosin Heavy Chains" by people in Profiles.
-
Lee CY, Bisig CG, Conrad MM, Ditamo Y, Previato de Almeida L, Dresser ME, Pezza RJ. Extranuclear Structural Components that Mediate Dynamic Chromosome Movements in Yeast Meiosis. Curr Biol. 2020 04 06; 30(7):1207-1216.e4.
-
Ardhanari M, Swaminathan S. Congenital ductus arteriosus aneurysm in association with MYH11 mutation: a case report. Cardiol Young. 2020 Jan; 30(1):123-125.
-
Arevalo JA, Lynn SK, Bagley JR, Brown LE, Costa PB, Galpin AJ. Lower-Limb Dominance, Performance, and Fiber Type in Resistance-trained Men. Med Sci Sports Exerc. 2018 05; 50(5):1054-1060.
-
Tobias IS, Lazauskas KK, Arevalo JA, Bagley JR, Brown LE, Galpin AJ. Fiber type-specific analysis of AMPK isoforms in human skeletal muscle: advancement in methods via capillary nanoimmunoassay. J Appl Physiol (1985). 2018 04 01; 124(4):840-849.
-
Fry AC, Housh TJ, Cramer JB, Weir JP, Beck TW, Schilling BK, Miller JD, Nicoll JX. Noninvasive Assessment of Skeletal Muscle Myosin Heavy Chain Expression in Trained and Untrained Men. J Strength Cond Res. 2017 Sep; 31(9):2355-2362.
-
Bagley JR, McLeland KA, Arevalo JA, Brown LE, Coburn JW, Galpin AJ. Skeletal Muscle Fatigability and Myosin Heavy Chain Fiber Type in Resistance Trained Men. J Strength Cond Res. 2017 Mar; 31(3):602-607.
-
Krishnan P, Purushothaman KR, Purushothaman M, Turnbull IC, Tarricone A, Vasquez M, Jain S, Baber U, Lascano RA, Kini AS, Sharma SK, Moreno PR. Enhanced neointimal fibroblast, myofibroblast content and altered extracellular matrix composition: Implications in the progression of human peripheral artery restenosis. Atherosclerosis. 2016 08; 251:226-233.
-
Landi D, Lockhart E, Miller SE, Datto M, Rehder C, Kanaly A, Thornburg CD. Report of a young girl with MYH9 mutation and review of the literature. J Pediatr Hematol Oncol. 2012 Oct; 34(7):538-40.
-
Lin CP, Adrianto I, Lessard CJ, Kelly JA, Kaufman KM, Guthridge JM, Freedman BI, Anaya JM, Alarcón-Riquelme ME, Pons-Estel BA, Martin J, Glenn S, Adler A, Bae SC, Park SY, Bang SY, Song YW, Boackle SA, Brown EE, Edberg JC, Alarcón GS, Petri MA, Criswell LA, Ramsey-Goldman R, Reveille JD, Vila LM, Gilkeson GS, Kamen DL, Ziegler J, Jacob CO, Rasmussen A, James JA, Kimberly RP, Merrill JT, Niewold TB, Scofield RH, Stevens AM, Tsao BP, Vyse TJ, Langefeld CD, Moser KL, Harley JB, Gaffney PM, Montgomery CG. Role of MYH9 and APOL1 in African and non-African populations with lupus nephritis. Genes Immun. 2012 Apr; 13(3):232-8.
-
Franceschini N, Voruganti VS, Haack K, Almasy L, Laston S, Goring HH, Umans JG, Lee ET, Best LG, Fabsitz RR, MacCluer JW, Howard BV, North KE, Cole SA. The association of the MYH9 gene and kidney outcomes in American Indians: the Strong Heart Family Study. Hum Genet. 2010 Mar; 127(3):295-301.